HTA has accepted for purchase 14,851,485 Class A Shares at a purchase price of $10.10 per share, for an aggregate cost of approximately $150,000,000, excluding fees and expenses relating to the tender offer. The 14,851,485 Class A Shares accepted for purchase in the tender offer represent approximately 25.9% of HTA's issued and outstanding Class A Shares as of July 18, 2012 and approximately 6.5% of HTA's issued and outstanding shares of common stock of all classes as of July 18, 2012.
Based on the final count by Computershare, Inc., the paying agent for the tender offer, and ARC Advisory Services, LLC, the depositary for the tender offer, a total of 22,611,970 Class A Shares were properly tendered and not properly withdrawn at or below the final purchase price of $10.10 per share. The 22,611,970 Class A Shares properly tendered and not properly withdrawn at or below the final purchase price of $10.10 per share represent approximately 39.4% of HTA's issued and outstanding Class A Shares as of July 18, 2012 and approximately 9.9% of HTA's issued and outstanding shares of common stock of all classes as of July 18, 2012.
Due to the oversubscription of the tender offer, stockholders who tendered and did not properly withdraw Class A Shares in the tender offer at or below the purchase price of $10.10 per share will have approximately 65.6% of their tendered Class A Shares purchased on a pro rata basis by HTA (other than "odd lot" holders, whose Class A Shares will be purchased on a priority basis).
The paying agent will promptly issue payment for the Class A Shares properly tendered and accepted for purchase in accordance with the terms and conditions of the tender offer. Class A Shares tendered and not accepted for purchase will be returned promptly to stockholders.
As a result of the settlement of the tender offer, HTA has approximately 42,519,915 Class A Shares outstanding, 57,284,082 shares of Class B-1 common stock outstanding, 57,284,082 shares of Class B-2 common stock outstanding, and 57,284,082 shares of Class B-3 common stock outstanding, for an aggregate of 214,372,161 shares of common stock of all classes outstanding.
Investor questions concerning the tender offer may be directed to the dealer manager for the tender offer, Wells Fargo Securities, LLC, at (877) 450-7515 (institutional stockholders), or the depositary for the tender offer, ARC Advisory Services, LLC, at (877) 373-2522 (retail stockholders).
This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any securities of HTA.
About Healthcare Trust of America, Inc.
Healthcare Trust of America, Inc. (NYSE: HTA), a publicly traded real estate investment trust, is a fully-integrated, leading owner of medical office buildings. HTA listed its shares on the New York Stock Exchange on June 6, 2012. HTA is a full-service real estate company focused on acquiring, owning and operating high-quality medical office buildings that are located on the campuses of nationally recognized healthcare systems in the major U.S. metropolitan areas. Since its formation in 2006, HTA has built a portfolio of properties that totals approximately $2.5 billion based on purchase price and is comprised of approximately 12.4 million square feet of gross leasable area located in 26 states. For more information on Healthcare Trust of America, Inc., please visit www.htareit.com.
This press release contains certain forward-looking statements. Forward-looking statements are based on current expectations, plans, estimates, assumptions and beliefs, including expectations, plans, estimates, assumptions and beliefs about HTA, stockholder value and earnings growth.
The forward-looking statements included in this press release are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond HTA's control. Although HTA believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, HTA's actual results and performance could differ materially from those set forth in the forward-looking statements. Factors which could have a material adverse effect on HTA's operations and future prospects include, but are not limited to:
changes in economic conditions affecting the healthcare property sector, the commercial real estate market and the credit market;
competition for acquisition of medical office buildings and other facilities that serve the healthcare industry;
economic fluctuations in certain states in which HTA's property investments are geographically concentrated;
retention of HTA's senior management team;
financial stability and solvency of HTA's tenants;
supply and demand for operating properties in the market areas in which HTA operates;
HTA's ability to acquire real properties, and to successfully operate those properties once acquired;
changes in property taxes;
legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry;
fluctuations in reimbursements from third party payors such as Medicare and Medicaid;
delays in liquidating defaulted mortgage loan investments;
changes in interest rates;
the availability of capital and financing;
restrictive covenants in HTA's credit facilities;
changes in HTA's credit ratings;
HTA's ability to remain qualified as a REIT; and
The risk factors set forth in HTA's 2011 Annual Report on Form 10-K for the year ended December 31, 2011 and its quarterly report on Form 10-Q for the quarter ended March 31, 2012.
Forward-looking statements speak only as of the date made. Except as otherwise required by the federal securities laws, HTA undertakes no obligation to update any forward-looking statements to reflect the events or circumstances arising after the date as of which they are made. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on the forward-looking statements included in this press release or that may be made elsewhere from time to time by, or on behalf of, HTA.